Steriles manufacturing remains one of the most challenging areas of the pharmaceutical industry from both a compliance and a technical perspective. The regulatory expectations continue to evolve, however slowly and new technology has the potential to massively change ways of working.
This meeting is a must for all those in senior roles, QPs and anyone who has an eye on the future in the sector.
Dr Martin Dearden - Cell and Gene Therapy Catapult
Dr Alan Heavey - Sterilization Solutions Ltd
Alan Moon - MHRA
Dr Simon Phillips - Nova Laboratories
For more details and to register please click here